Fig. 1a–h.
Flow cytometric phenotyping of in vitro–generated DCs from patient 008. a Gating on forward-side scatter including all potential DCs (R2). b DCs are further gated by low or negative staining with a lineage cocktail including mAbs for CD3, CD14 and CD19 (R3). c–h Fluorescence intensities of gated lineage-negative cells stained with mAbs for relevant DC surface markers